Atyr Pharma logo

Atyr Pharma share price today

(ATYR)

Atyr Pharma share price is $3.77 & ₹321.47 as on 27 Dec 2024, 2.30 'hrs' IST

$3.77

0.35

(10.23%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Atyr Pharma share price in Dollar and Rupees. Guide to invest in Atyr Pharma from India. Also see the sentimental analysis on Indian investors investing in Atyr Pharma. Get details on the Indian mutual funds that are investing in Atyr Pharma. Get Analyst recommendations and forecasts along with all the Atyr Pharma's financials.

Atyr Pharma share price movements

  • Today's Low: $3.35
    Today's High: $3.77

    Day's Volatility :11.14%

  • 52 Weeks Low: $1.42
    52 Weeks High: $3.80

    52 Weeks Volatility :62.63%

Atyr Pharma Returns

PeriodAtyr Pharma IncIndex (Russel 2000)
3 Months
93.22%
0.0%
6 Months
119.23%
0.0%
1 Year
87.91%
0.0%
3 Years
87.91%
-21.1%

Atyr Pharma Key Statistics

in dollars & INR

Previous Close
$3.42
Open
$3.43
Today's High
$3.77
Today's Low
$3.35
Market Capitalization
$144.0M
Today's Volume
$371.7K
52 Week High
$3.8001
52 Week Low
$1.42
Revenue TTM
$588.0K
EBITDA
$-61.8M
Earnings Per Share (EPS)
$-0.9
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-61.76%

How to invest in Atyr Pharma from India?

It is very easy for Indian residents to invest directly in Atyr Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atyr Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atyr Pharma or ATYR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atyr Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atyr Pharma shares which would translate to 0.226 fractional shares of Atyr Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atyr Pharma, in just a few clicks!

Returns in Atyr Pharma for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atyr Pharma investment value today

Current value as on today

₹2,09,468

Returns

₹1,09,468

(+109.47%)

Returns from Atyr Pharma Stock

₹1,07,143 (+107.14%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Atyr Pharma

54%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Atyr Pharma on INDmoney from India has grown in the last 30 days as on Dec 27, 2024. 54% more investors are searching Atyr Pharma in the last 30 days versus the previous period.

Analyst Recommendation on Atyr Pharma

Analyst Forecast on Atyr Pharma

What analysts predicted

Upside of 483.55%

Current:

$3.77

Target:

$22.00

Insights on Atyr Pharma

  • Price Movement

    In the last 7 days, ATYR stock has moved up by 8.6%

Atyr Pharma Technicals Summary

Sell

Neutral

Buy

Atyr Pharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Atyr Pharma Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Atyr Pharma Inc
-0.58%
119.23%
87.91%
87.91%
87.91%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.02%
-18.97%
11.91%
91.19%
Biontech Se
-3.72%
42.02%
7.95%
-52.72%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
0.1%
24.29%
44.19%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-12.92%
-0.27%
83.92%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Atyr Pharma Inc
NA
NA
NA
-0.91
-0.62
-0.33
NA
1.08
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Atyr Pharma Inc
NA
$144.0M
87.91%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Atyr Pharma

atyr pharma (nasdaq: life) is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of physiocrine biology, a newly discovered set of physiological modulators. the company's lead candidate, resolaris™, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune component. resolaris is currently in a phase 1b/2 clinical trial in adult patients with facioscapulohumeral muscular dystrophy (fshd); a phase 1b/2 trial in adult patients with limb girdle muscular dystrophy (lgmd) 2b or fshd; and a phase 1b/2 trial in patients with an early onset form of fshd. to protect this pipeline, atyr built an intellectual property estate comprising 70 issued or allowed patents and over 240 pending patent applications that are solely owned or exclusively licensed by atyr. atyr's key programs are currently focused on severe, rare diseases characterized by immune dysregulation
Organization
Atyr Pharma
Employees
56
CEO
Dr. Sanjay S. Shukla M.D., M.S.
Industry
Miscellaneous

Management People of Atyr Pharma

NameTitle
Dr. Sanjay S. Shukla M.D., M.S.
President, CEO & Director
Ms. Jill M. Broadfoot CPA
Chief Financial Officer
Ms. Nancy E. Denyes Krueger J.D.
General Counsel & Corporate Secretary
Xiang-Lei Yang Ph.D.
Founder
Dr. Jayant Aphale MBA, Ph.D.
Vice President of Technical Operations
Ms. Ashlee Dunston
Director of Investor Relations & Corporate Communications
Mr. Peter Villiger
Vice President of Corporate Development
Ms. Danielle Campbell
VP of Human Resource
Dr. Leslie Nangle Ph.D.
Vice President of Research
Dr. Ying J. Buechler Ph.D.
Executive Director of Biologics Development & Manufacturing

Important FAQs about investing in Atyr Pharma from India :

What is Atyr Pharma share price today?

Atyr Pharma share price today stands at $3.77, Open: $3.43 ; Previous Close: $3.42 ; High: $3.77 ; Low: $3.35 ; 52 Week High: $3.80 ; 52 Week Low: $1.42. The stock opens at $3.43, after a previous close of $3.42. The stock reached a daily high of $3.77 and a low of $3.35, with a 52-week high of $3.80 and a 52-week low of $1.42.

Can Indians buy Atyr Pharma shares?

Yes, Indians can invest in the Atyr Pharma (ATYR) from India.

With INDmoney, you can buy Atyr Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Atyr Pharma at zero transaction cost.

How can I buy Atyr Pharma shares from India?

It is very easy to buy Atyr Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atyr Pharma be purchased?

Yes, you can buy fractional shares of Atyr Pharma with INDmoney app.

What are the documents required to start investing in Atyr Pharma stocks?

To start investing in Atyr Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Atyr Pharma

Today’s highest price of Atyr Pharma (ATYR) is $3.77.

Today’s lowest price of Atyr Pharma (ATYR) is $3.35.

What is today's market capitalisation of Atyr Pharma

Today's market capitalisation of Atyr Pharma ATYR is 144.0M

What is the 52 Week High and Low Range of Atyr Pharma

  • 52 Week High

    $3.80

  • 52 Week Low

    $1.42

What are the historical returns of Atyr Pharma?

  • 1 Month Returns

    -0.58%

  • 3 Months Returns

    119.23%

  • 1 Year Returns

    87.91%

  • 5 Years Returns

    87.91%

Who is the Chief Executive Officer (CEO) of Atyr Pharma

Dr. Sanjay S. Shukla M.D., M.S. is the current Chief Executive Officer (CEO) of Atyr Pharma.